Aditx Therapeutics (ADTX)
(Delayed Data from NSDQ)
$2.41 USD
+0.02 (0.84%)
Updated Apr 29, 2024 03:59 PM ET
After-Market: $2.40 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-3.33 | 0.00% |
Earnings Summary
For their last quarter, Aditx Therapeutics (ADTX) reported earnings of -$48.77 per share, missing the Zacks Consensus Estimate of -$5.99 per share. This reflects a negative earnings surprise of 714.19%. Look out for ADTX's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$3.33 per share, reflecting a year-over-year increase of 93.65%.
Earnings History
Price & Consensus
Zacks News for ADTX
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Tops Revenue Estimates
ADTX: What are Zacks experts saying now?
Zacks Private Portfolio Services